Mode
Text Size
Log in / Sign up

Thyroid Cancer Brain Metastases

Part of Cancer

1 published article · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Cancer

Related studies from across the Cancer family.

Nivolumab monotherapy yielded 12-month progression-free survival in metastatic anaplastic thyroid cancer
Oncology Sys. Review
Nivolumab monotherapy yielded 12-month progression-free survival in metastatic anaplastic thyroid cancer Off-label immunotherapy may help some patients with metastatic anaplastic thyroid cancer
This case report describes a 76-year-old female with metastatic anaplastic thyroid cancer treated with off-label nivolumab monotherapy. The …
A single case report suggests off-label nivolumab helped a 76-year-old woman live longer with metastatic anaplastic thyroid cancer.
Meta-analysis finds germline LTS and somatic TERT variants are mutually exclusive in thyroid cancer and melanoma
Genetics & Precision Medicine Meta-analysis
Meta-analysis finds germline LTS and somatic TERT variants are mutually exclusive in thyroid cancer and melanoma Two different cancer drivers do not appear together in these tumors
This meta-analysis of retrospective observational cohorts examined germline long-telomere syndrome variants and somatic TERT promoter altera…
A large review of nearly 2,000 adults with thyroid cancer or melanoma found that two specific genetic changes never occur in the same tumor.
Case report details multimodal treatment for aggressive thyroid carcinoma
Oncology Sys. Review
Case report details multimodal treatment for aggressive thyroid carcinoma First new treatment combination in six months stabilizes advanced thyroid cancer
A 61-year-old man with papillary thyroid carcinoma achieved disease stabilization after thyroidectomy, radiotherapy, and targeted therapy. T…
A 61-year-old man with advanced thyroid cancer saw his disease stop growing after a specific mix of treatments within six months of his diag…
Symptom Network Changes in Differentiated Thyroid Cancer Patients Undergoing Radioactive Iodine Therapy
Oncology Cohort
Symptom Network Changes in Differentiated Thyroid Cancer Patients Undergoing Radioactive Iodine Therapy Radioactive iodine therapy changes how symptoms connect in patients
This prospective cohort study of 520 patients with differentiated thyroid cancer found that radioactive iodine therapy significantly reorgan…
New research shows that radioactive iodine therapy reshapes how physical and psychological symptoms interact in people with thyroid cancer.
Central lymph node ratio threshold predicts lateral lymph node metastasis in pediatric differentiated thyroid carcinoma
Diabetes & Endocrinology Cohort
Central lymph node ratio threshold predicts lateral lymph node metastasis in pediatric differentiated thyroid carcinoma One Number Might Predict Thyroid Cancer Spread in Children
This retrospective cohort study evaluated pediatric patients with differentiated thyroid carcinoma aged ≤14 years.
A simple number helps doctors predict if thyroid cancer will spread to side neck nodes in children under 14 years old.
TIRADS and Bethesda systems predict thyroid malignancy in 70 patients at Baghdad Teaching Hospital
Radiology & Imaging Cohort
TIRADS and Bethesda systems predict thyroid malignancy in 70 patients at Baghdad Teaching Hospital Family history and neck swelling signal higher risk of thyroid cancer
This prospective cross-sectional study evaluated 70 patients with thyroid complaints at Baghdad Teaching Hospital.
A new look at thyroid nodules shows that family history and neck swelling are key signs of cancer, helping doctors catch it sooner.
Case series describes four clear cell variant papillary thyroid carcinoma cases with NCOA4-RET fusions
Oncology Sys. Review
Case series describes four clear cell variant papillary thyroid carcinoma cases with NCOA4-RET fusions Rare Thyroid Cancer Has Unique Genetic Signature
This case series with literature review describes four pathologically confirmed cases of clear cell variant of papillary thyroid carcinoma d…
A rare thyroid cancer type may have a specific genetic cause that doctors can now look for.
Machine learning models predict survival in lymph-node-positive medullary thyroid carcinoma
Oncology Cohort
Machine learning models predict survival in lymph-node-positive medullary thyroid carcinoma A Machine Learning Tool Now Predicts Survival for One Tricky Thyroid Cancer
This cohort study evaluated machine learning models for predicting survival in patients with lymph-node-positive medullary thyroid carcinoma…
A new AI tool predicts survival for aggressive medullary thyroid cancer that has spread to lymph nodes, revealing that skipping surgery is t…
Autopsy study finds 55% thyroid nodular disease prevalence in Mexico City hospital patients
Neurology Cohort
Autopsy study finds 55% thyroid nodular disease prevalence in Mexico City hospital patients Autopsy study finds high thyroid nodule rates in Mexico City, no link to salt iodination
A retrospective cohort study of 487 autopsies from a third-level hospital in Mexico City found a thyroid nodular disease prevalence of 55% a…
Autopsies in Mexico City reveal thyroid nodules are very common, yet changing salt iodination rules did not increase their rates.
Encorafenib plus binimetinib maintains quality of life in BRAF V600E-mutated thyroid cancer
Oncology Phase II
Encorafenib plus binimetinib maintains quality of life in BRAF V600E-mutated thyroid cancer Can new drugs help advanced thyroid cancer patients keep their daily life stable?
An uncontrolled phase 2 trial of 22 patients with BRAF V600E-mutated thyroid cancer found encorafenib plus binimetinib was associated with g…
A new drug combination helped advanced thyroid cancer patients maintain daily life stability without worsening their quality of life during …
Elevated neutrophil-to-lymphocyte ratio predicts brain metastasis risk in lung cancer patients
Oncology Meta-analysis
Elevated neutrophil-to-lymphocyte ratio predicts brain metastasis risk in lung cancer patients Could a simple blood test help find who is most at risk for brain metastasis from lung cancer?
This systematic review and meta-analysis evaluated three immune inflammatory markers in 3,643 participants with lung cancer.
A simple blood test showing high inflammation markers can predict who is most likely to develop brain metastasis from lung cancer.
Case report describes complete remission in PDTC with combined radiotherapy and chemotherapy
Oncology Sys. Review
Case report describes complete remission in PDTC with combined radiotherapy and chemotherapy Case report describes complete remission in advanced thyroid cancer patient after combined treatment
A case report and literature review examined a 55-year-old male with advanced poorly differentiated thyroid carcinoma (PDTC).
A 55-year-old man with advanced thyroid cancer achieved complete remission after combining local radiotherapy and intravenous chemotherapy.